Zacks Investment Research upgraded shares of Udg Healthcare Plc (NASDAQ:UDHCF) from a hold rating to a buy rating in a research report sent to investors on Tuesday morning. Zacks Investment Research currently has $9.00 price objective on the stock.
According to Zacks, “UDG Healthcare plc provide services to the healthcare industry. The company’s operating segment consists of Ashfield Commercial & Medical Services, Sharp Packaging Services and Supply Chain Services. Ashfield Commercial & Medical Services division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services. Sharp Packaging Service division provides contract packaging and clinical trial packaging services. Supply Chain Services provides outsourced sales, marketing, distribution and engineering services. UDG Healthcare plc operates primarily in US, UK, Ireland and Germany. UDG Healthcare plc is based in Dublin, the Republic of Ireland. “
Shares of Udg Healthcare Plc (UDHCF) traded up 35.21% during trading on Tuesday, hitting $10.83. 95 shares of the stock were exchanged. The stock has a market cap of $2.68 billion and a price-to-earnings ratio of 13.21. Udg Healthcare Plc has a 12-month low of $8.01 and a 12-month high of $10.83. The stock’s 50 day moving average is $10.83 and its 200-day moving average is $9.09.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Udg Healthcare Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare Plc and related companies with MarketBeat.com's FREE daily email newsletter.